[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Use of Circulating Tumor DNA for Curative-Intent Solid Tumo...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled Financial Disclosure by Clinical Inves...[ Price : $8.95]
Federal Register notice: FDA announces a 1/10 Anesthetic and Analgesic Drug Products Advisory Committee meeting to discuss a Seika...[ Price : $8.95]
Former FDA Commissioner Scott Gottlieb predicts a difficult path for Robert F. Kennedy Jr. to win Senate confirmation as HHS secre...[ Price : $8.95]
Johnson & Johnson files two supplemental BLAs for Tremfya (guselkumab) for treating certain children with moderate-to-severe plaqu...[ Price : $8.95]
FDA issues Applied Therapeutics a complete response letter on its NDA for govorestat and its use for treating classic galactosemia...[ Price : $8.95]
FDA approves a Mentor Worldwide PMA for its MemoryGel Enhance Breast Implants for reconstruction breast surgery in post-mastectomy...[ Price : $8.95]
FDA publishes a guidance to help sponsors planning to use circulating tumor DNA as a biomarker in some cancer trials.